Comparison between Accretion Pharmaceuticals IPO and Connplex Cinemas IPO.
Accretion Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Connplex Cinemas IPO is a SME Bookbuilding proposed to list at NSE SME.
| Accretion Pharmaceuticals IPO | Connplex Cinemas IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Jawa Capital Services Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Spread X Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Pharmaceuticals IPO is up to ₹28.26 Cr whereas the issue size of the Connplex Cinemas IPO is up to ₹85.74 Cr. The final issue price of Accretion Pharmaceuticals IPO is ₹101.00 per share and of Connplex Cinemas IPO is ₹177.00 per share.
| Accretion Pharmaceuticals IPO | Connplex Cinemas IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹96.00 per share | ₹168.00 per share |
| Issue Price (Upper) | ₹101.00 per share | ₹177.00 per share |
| Issue Price (Final) | ₹101.00 per share | ₹177.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 800 shares |
| Fresh Issue Size | 27,98,400 shares | 48,44,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.26 Cr | up to ₹85.74 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,98,400 shares | 48,44,000 shares |
| Issue Size Total (Amount) | up to ₹28.26 Cr | up to ₹85.74 Cr |
Accretion Pharmaceuticals IPO opens on May 14, 2025, while Connplex Cinemas IPO opens on Aug 07, 2025. The closing date of Accretion Pharmaceuticals IPO and Connplex Cinemas IPO is May 16, 2025, and Aug 11, 2025, respectively.
| Accretion Pharmaceuticals IPO | Connplex Cinemas IPO | |
|---|---|---|
| Anchor Bid Date | May 13, 2025 | Aug 06, 2025 |
| Issue Open | May 14, 2025 | Aug 07, 2025 |
| Issue Close | May 16, 2025 | Aug 11, 2025 |
| Basis Of Allotment (Tentative) | May 19, 2025 | Aug 12, 2025 |
| Initiation of Refunds (Tentative) | May 20, 2025 | Aug 13, 2025 |
| Credit of Share (Tentative) | May 20, 2025 | Aug 13, 2025 |
| Listing date (Tentative) | May 21, 2025 | Aug 14, 2025 |
| Anchor Lockin End date 1 | Jun 18, 2025 | Sep 11, 2025 |
| Anchor Lockin End date 2 | Aug 17, 2025 | Nov 10, 2025 |
Accretion Pharmaceuticals IPO P/E ratio is 21.29, as compared to Connplex Cinemas IPO P/E ratio of 13.04.
| Accretion Pharmaceuticals IPO | Connplex Cinemas IPO | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)
| EBITDA | ||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 95.36 | ||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | 69.90 | ||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.29 | 13.04 | ||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹112.27 Cr. | ₹338.07 Cr. | ||||||||||||||||||||||||||||||||||||||||
| ROE | 72.47% | 127.28% | ||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.73% | 98.25% | ||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.52 | 0.03 | ||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.74 | ₹13.58 | ||||||||||||||||||||||||||||||||||||||||
| RoNW | 72.47% | 77.78% | ||||||||||||||||||||||||||||||||||||||||
In the Accretion Pharmaceuticals IPO Retail Individual Investors (RII) are offered 12,22,800 shares while in Connplex Cinemas IPO retail investors are offered 12,22,800 shares. Qualified Institutional Buyers (QIB) are offered 1,41,600 shares in Accretion Pharmaceuticals IPO and 9,68,800 shares in Connplex Cinemas IPO.
| Accretion Pharmaceuticals IPO | Connplex Cinemas IPO | |
|---|---|---|
| Anchor Investor Reserveration | 2,11,200 shares | 14,52,000 shares |
| Market Maker Reserveration | 1,47,600 shares | 2,56,000 shares |
| QIB | 1,41,600 shares | 9,68,800 shares |
| NII | 12,22,800 shares | 7,27,200 shares |
| RII | 12,22,800 shares | 16,96,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 27,98,400 shares | 48,44,000 shares |
Accretion Pharmaceuticals IPO subscribed 7.67x in total, whereas Connplex Cinemas IPO subscribed 35.67x.
| Accretion Pharmaceuticals IPO | Connplex Cinemas IPO | |
|---|---|---|
| QIB (times) | 12.14x | 44.21x |
| NII (times) | 4.28x | 49.75x |
| Big NII (times) | 58.98x | |
| Small NII (times) | 31.28x | |
| RII (times) | 10.54x | 24.75x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.67x | 35.67x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
